title: Guidance concerning the use of glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus.
abstract: Glycated haemoglobin (HbA1c) assessment for the diagnosis of diabetes mellitus overcomes many practical problems associated with traditional blood glucose measurements. However, the test is not without limitations of which the medical practitioner needs to be aware. The possibility of an individual having a medical condition that interferes with the test should always be considered, even though these conditions are rare in most Australian communities. Appropriately used, HbA1c assessment should provide a cost-effective, efficient and simple tool for the early diagnosis of type 2 diabetes.
authors.affiliation: Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. Michael.d'Emden@health.qld.gov.au.
authors.forename: Michael C
authors.initials: MC
authors.lastname: d'Emden
authors.affiliation: Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia.
authors.forename: Jonathan E
authors.initials: JE
authors.lastname: Shaw
authors.affiliation: St Vincent's Hospital, Sydney, NSW, Australia.
authors.forename: Graham R
authors.initials: GR
authors.lastname: Jones
authors.affiliation: Westmead Hospital, Sydney, NSW, Australia.
authors.forename: N Wah
authors.initials: NW
authors.lastname: Cheung
mesh_terms: D001315:Australia; D003920:Diabetes Mellitus; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis*; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D009313:National Health Programs; D012955:Societies, Medical
chemical_list: D006442:Glycated Hemoglobin